Mu opioid receptors (MORs) have been extensively studied for their addictive properties that are thought to operate through the control of reward processes. While the importance of MORs in reward is generally attributed to their presence in the mesocorticolimbic circuitry, their role in the medial habenula (MHb), the structure in which MORs are most densely expressed, remains unexplored to date. This is quite surprising given the increasing literature on the habenula’s role in addiction as well as reward/aversion processes. Here we generated a conditional knockout mouse model that lacks MORs solely in the MHb and we investigated the contribution of habenular MORs in brain functions and behavioural outcomes with emphasis on reward, aversion ...
Persistent vulnerability to relapse represents a major challenge in the treatment of drug addiction....
The epithalamic lateral habenula (LHb) regulates monoaminergic systems and contributes to the expres...
Now published in Neuropsychopharmacology doi: 10.1038/s41386-020-00927-xInternational audienceUnders...
Mu opioid receptors (MORs) have been extensively studied for their addictive properties that are tho...
The medial habenula (MHb) is considered a brain center regulating aversive states. The mu opioid rec...
BACKGROUND: Mu opioid receptors (MORs) are central to pain control, drug reward, and addictive behav...
μ-Opioid receptors (MORs) are densely expressed in different brain regions known to mediate reward. ...
BACKGROUND: Mu opioid receptors (MORs) are central to pain control, drug reward, and addictive behav...
μ-Opioid receptors (MORs) are densely expressed in different brain regions known to mediate reward. ...
While the contribution of Mu Opioid Receptors (MORs) to hedonic aspects of reward processing is well...
Mu opioid receptors mediate the strong analgesic and addictive properties of morphine and heroin;how...
Opioid drugs, such as morphine, bind to opioid receptors in the brain and provide an analgesic, rewa...
International audienceThe lateral habenula encodes aversive stimuli contributing to negative emotion...
Although the expression of the morphine (MOR) withdrawal syndrome is more marked in male mice than i...
The reinforcing and psychomotor effects of morphine involve opiate stimulation of the dopaminergic s...
Persistent vulnerability to relapse represents a major challenge in the treatment of drug addiction....
The epithalamic lateral habenula (LHb) regulates monoaminergic systems and contributes to the expres...
Now published in Neuropsychopharmacology doi: 10.1038/s41386-020-00927-xInternational audienceUnders...
Mu opioid receptors (MORs) have been extensively studied for their addictive properties that are tho...
The medial habenula (MHb) is considered a brain center regulating aversive states. The mu opioid rec...
BACKGROUND: Mu opioid receptors (MORs) are central to pain control, drug reward, and addictive behav...
μ-Opioid receptors (MORs) are densely expressed in different brain regions known to mediate reward. ...
BACKGROUND: Mu opioid receptors (MORs) are central to pain control, drug reward, and addictive behav...
μ-Opioid receptors (MORs) are densely expressed in different brain regions known to mediate reward. ...
While the contribution of Mu Opioid Receptors (MORs) to hedonic aspects of reward processing is well...
Mu opioid receptors mediate the strong analgesic and addictive properties of morphine and heroin;how...
Opioid drugs, such as morphine, bind to opioid receptors in the brain and provide an analgesic, rewa...
International audienceThe lateral habenula encodes aversive stimuli contributing to negative emotion...
Although the expression of the morphine (MOR) withdrawal syndrome is more marked in male mice than i...
The reinforcing and psychomotor effects of morphine involve opiate stimulation of the dopaminergic s...
Persistent vulnerability to relapse represents a major challenge in the treatment of drug addiction....
The epithalamic lateral habenula (LHb) regulates monoaminergic systems and contributes to the expres...
Now published in Neuropsychopharmacology doi: 10.1038/s41386-020-00927-xInternational audienceUnders...